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Background: Thus far, little work in bioethics has specifically focused on global health research priority-setting. Yet
features of global health research priority-setting raise ethical considerations and concerns related to health justice.
For example, such processes are often exclusively disease-driven, meaning they rely heavily on burden of disease
considerations. They, therefore, tend to undervalue non-biomedical research topics, which have been identified as
essential to helping reduce health disparities. In recognition of these ethical concerns and the limited scholarship
and dialogue addressing them, we convened an international workshop in September 2015. The workshop aimed
to initiate discussion on the appropriate relationship between global and national levels of health research priority-
setting and to begin exploring what might be ethically required for priority-setting at each of those levels.
Main text: This paper comprises our reflections following the workshop. Its main objective is to launch a research
agenda for the ethics of global health research priority-setting. We identify three domains of global health research
priority-setting—scope, underlying values and substantive requirements, and procedural considerations. For each domain,
specific research questions are highlighted and why they need to be explored is explained. Some preliminary thoughts
and normative arguments as to how the research questions might be answered are also offered. For example, we
provide initial ideas about the appropriate relationship between different priority-setting levels and what values and
substantive considerations should guide or underpin global health research priority-setting as a matter of justice.
Conclusion: We anticipate that framing a new research agenda for the ethics of global health research priority-setting
will spur ethicists, researchers, and policymakers to refocus their efforts on developing more rigorous and ethically sound
approaches to priority-setting.
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Research ethics has traditionally focused on issues that
arise within the researcher-participant relationship such
as ensuring informed consent, a favourable risk-benefit
ratio, and fair subject selection. In recognition of the
growing global context of research and lack of benefits
accruing to vulnerable populations, particularly in low
and middle-income countries (LMICs), Benatar and
Singer ([5], p. 826) argued “a new, proactive research
ethics... must ultimately be concerned with reducing
inequities in global health and achieving justice in
health research and healthcare.” This call to expand* Correspondence: bridget.pratt@unimelb.edu.au
1Nossal Institute for Global Health and Centre for Health Equity, School of
Population and Global Health, University of Melbourne, 207 Bouverie St
Street, Carlton, VIC 3053, Australia
Full list of author information is available at the end of the article
© The Author(s). 2018 Open Access This artic
International License (http://creativecommons
reproduction in any medium, provided you g
the Creative Commons license, and indicate if
(http://creativecommons.org/publicdomain/zethe scope of research ethics has been reiterated by
others [19, 22, 34]. It is also consistent with calls to
expand the more general bioethics agenda to focus on
population health and health disparities between and
within countries [12, 23].
When the scope of research ethics encompasses efforts
to promote health justice domestically and globally, the
targets of ethical analysis expand to include health re-
search priority-setting and resource allocation, research
translation, and research capacity strengthening [6, 34]. In
this paper, we focus on the first of those targets—priority-
setting in research, particularly in relation to global health
research. We define global health research as research
addressing health problems worldwide, including those of
the most disadvantaged, who live primarily (but not exclu-
sively) in LMICs [24, 31].le is distributed under the terms of the Creative Commons Attribution 4.0
.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
ive appropriate credit to the original author(s) and the source, provide a link to
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tised matter to the achievement of health justice. While
largely setting aside ongoing debates about the scope
and meaning of health justice, as they are not the focus
of our paper, we adopt a middle-ground position: to
achieve health justice is to bring individuals worldwide
up to at least a decent level of health, with some priority
going to those who are worst-off or disadvantaged.1
Achieving health justice requires the provision of public
health and healthcare goods and services, establishing
institutional structures for health, and having broader
social arrangements (political, legal, economic, and cul-
tural) that are organized to promote and sustain individ-
uals’ health [13, 39, 44].
Yet whether individuals worldwide, including the vul-
nerable and disadvantaged, receive preventative care and
treatment for their illnesses in part depends on what
public health interventions and what medicines have
been developed and whether health systems can deliver
them efficiently and affordably. This, in turn, depends
on what global health research has been prioritised and
performed. Where global health research does not focus
on particular health conditions (e.g. neglected tropical
diseases), effective public health interventions and medi-
cines will not be developed for them. Where global
health research does not generate new knowledge on
strategies for those interventions and medicines’ delivery
and financing, health systems will not be optimised to
promote population health and to reduce health dispar-
ities. As a result, some individuals, especially in LMICs,
will be more likely to get preventable illnesses and to
lack access to effective treatments for them.
Despite significant scholarship on research ethics and
the ethics of healthcare resource allocation, limited work
in bioethics has specifically focused on health research
priority-setting. That existing work has largely concen-
trated on the lack of resources allocated to research on
health problems primarily experienced in LMICs. In
1990, the Commission on Health Research for Develop-
ment’s landmark report, Health research: Essential link
to equity in development estimated that only 5% of the
world’s resources for health research were being applied
to the health problems of LMICs, where 93% of the
world’s preventable deaths occurred [10]. The disparity
subsequently became known as the 10/90 gap and there
has been much consideration about how it should be ad-
dressed by philosophers, bioethicists, policymakers, and
organisations such as the Council on Health Research
for Development and the World Health Organization
[28, 32, 46]. There continues to be significant effort glo-
bally, often led from the global south, to push for
decision-making for research to move to LMICs and to
support capacity strengthening initiatives aimed at pro-
moting that shift.Beyond the still relevant 10/90 gap, we draw attention
to three aspects of global health research priority-setting
that raise ethical considerations and concerns connected
to health justice. First, priority-setting occurs at different
levels, with global priorities often influencing and pos-
sibly determining national priorities for health research
in LMICs. It has been argued that states—rather than
global actors—should be primarily responsible for ensur-
ing their population’s health and, in effect, setting their
national research priorities [35]. The complex and varied
nature of health systems between countries means local
stakeholders are often better situated to identify national
research priorities that advance population health and/or
contribute to the reduction of health disparities in their
countries [7]. This raises a key ethical question: what
should the appropriate relationship between different
levels of research priority-setting comprise? Should na-
tional priorities, for example, direct global priorities or
vice versa? A lack of ethical debate and guidance exists
on this topic.
Second, there is also a lack of discussion and consen-
sus in the bioethics literature on what values ought to be
reflected and what associated substantive requirements
ought to be used in global health research
priority-setting. Nuyens ([29], p. 320) affirms that health
research priority-setting is a “value-driven and political
activity” and should, in particular, be driven by the aim
of advancing health equity. This is consistent with our
position that global health research priority-setting has
an essential role to play in promoting health justice and
with recommendations made at global ministerial sum-
mits that health research should help reduce health dis-
parities between and within countries [26]. However, no
specific substantive requirements for equity-oriented
health research priority-setting have been described to
guide policymakers [36]. There are also other values and
substantive requirements related to them that should be
included in deliberations about global health research
priority-setting. What they are and how they should be
reflected/implemented in priority-setting processes
requires further investigation.
Third, also of ethical concern are the processes through
which global health research priorities are set. At the
global level, such processes have tended to be top-down,
reliant on a limited consultative process, and unable to
consider fine-grained local issues [2]. It has been sug-
gested that global health justice demands a system of
shared health governance, under which global priorities
reflect the true consensus of global, national, and
sub-national actors [35]. Additionally, global health re-
search priority-setting processes are often exclusively
disease-driven, meaning they rely heavily on burden of
disease considerations. Such processes tend to under-
value non-biomedical research, resulting in the
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and more basic science and clinical research priorities
[37]. This is concerning from a health justice perspective
because implementation research, health systems re-
search, and research on broader social determinants of
health are required to address the health needs of indi-
viduals worldwide, particularly the vulnerable and disad-
vantaged [4, 47, 48]. Another key question to explore is
then: what is required for fair and just global health re-
search priority-setting processes?
In recognition of these ethical concerns and the lim-
ited scholarship and dialogue addressing them, we con-
vened an international workshop of health researchers,
research managers, philosophers, lawyers, bioethicists
and ethics review committee members in September
2015. The workshop aimed to initiate discussion on the
relationship between global and national levels of
priority-setting and to start thinking about what might
be ethically required for global health research
priority-setting at each of these levels. The workshop
aims were then primarily exploratory. Given the lack of
thinking and work on the ethics of global health
research priority-setting, the intent was to articulate and
discuss initial ideas on the two topics. No attempt was
made to generate a consensus position based on the
workshop discussions. Workshop speakers and partici-
pants spanned five continents and twelve countries:
Botswana, Uganda, India, South Africa, Ghana,
Australia, Canada, Pakistan, UK, USA, Zimbabwe and
Zambia. The structure of the workshop was a mix of for-
mal presentations and extensive group interactions; their
content informed this paper. We indicate throughout
the paper where particular ideas came from workshop
speakers or participants and where broad (though gener-
ally not overall) support amongst workshop attendees
existed for certain ideas. However, we emphasise that
the paper is not a product of the workshop but rather a
set of reflections arising out of it. It describes our think-
ing on global health research priority-setting in light of
the workshop’s presentation and discussion content.
The main aim of the paper is to launch a research
agenda for the ethics of global health research
priority-setting. We identify three domains of research
priority-setting—scope, underlying values and substan-
tive requirements, and procedural considerations. For
each domain, we highlight specific research questions
and explain why they need to be explored. We also offer
some preliminary thoughts and normative arguments on
how the research questions might be answered. For ex-
ample, we provide initial ideas about the appropriate re-
lationship between different priority-setting levels and
what values and substantive considerations should guide
or underpin global health research priority-setting as a
matter of justice.The paper comprises an initial attempt to outline and
broadly structure future research directions. As an
agenda setting paper, it seeks to lay out broad claims
about the terrain rather than set policy (which would
clearly require wider input and consensus). Ultimately,
our intent is to contribute to a “new proactive” research
ethics agenda by drawing attention to domains where fu-
ture bioethics research on priority-setting is needed and
by providing preliminary ideas in relation to these areas.
It is hoped that our initial attempt to define these issues
will be met with critical attention and spur future inves-
tigations by ethicists, researchers, and policymakers.
Main text
Scope
In any discussion about the ethics of global health
research priority-setting, the scope of the priorities to be
set must first be clarified. Three dimensions can be iden-
tified along which the scope of priority-setting decisions
might vary: the geographic region or entity to which the
decisions apply, their macro or micro level focus (cat-
egories of research versus specific research questions),
and the sources of research funding to which resultant
priorities will apply. Any particular priority-setting exer-
cise may be resolved into these dimensions.
The first dimension might be understood to capture
the level at which priority-setting is undertaken. Work-
shop participants repeatedly emphasised that global
health research priority-setting can occur at multiple,
distinct levels that encompass global and national levels
but also include funder, consortia, and institutional
levels. At the national level, priorities are generally set
for the health research that is supported within a par-
ticular country. It entails LMICs and high-income coun-
tries alike setting their own domestic health research
priorities as well as high-income countries including
health problems primarily experienced in LMICs in their
priorities. Depending on the structures and health con-
cerns within a given country, this priority-setting might
stipulate fine-grained or broad brush research priorities.
At the global level, research priorities are set that apply
across countries worldwide and/or across regions and
there is potential for many more actors to be involved in
the decision-making process. The global health land-
scape has expanded tremendously over the past two
decades, with many new actors emerging such as global
health organisations (e.g. GAVI, Global Fund), philan-
thropic foundations (e.g. Gates Foundation), and product
development partnerships (e.g. Drugs for Neglected
Tropical Diseases) [31]. These priorities are, therefore,
likely to be broad ranging and, in principle, based on
global or regional trends and needs. Global health re-
search consortia (alliances of universities, research insti-
tutions, and other organisations) often set priorities that
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their member institutions. These priorities are likely to
be driven in part by the concerns, interests, and goals of
a given consortium and its members. How a particular
donor sets priorities for the global health research it
funds will only apply to eligible applicants and recipients
and is likely to be driven by its broad institutional goals
and interests. Finally, research institutions set priorities
that apply to their internal funding schemes, which are
typically open to their staff.
The second dimension refers to the intended breadth
or specificity of the outputs of global health research
priority-setting. Depending on whether broad or narrow
priorities are sought, priority-setting may involve making
macro-level decisions about broad areas of health
research or micro-level decisions about specific health
research questions. As affirmed in the Council on Health
Research for Development’s Manual for Health Research
Priority-setting, there must be follow-up action after
identifying broad priority areas, which includes translat-
ing them into specific research questions [30]. For ex-
ample, a ‘macro’ level decision could be: should HIV
prevention research be prioritised over research on fam-
ily violence prevention? A ‘micro’ level decision related
to the priority area of HIV prevention research might
then be: should a research question about the efficacy of
a new PrEP regimen be ranked higher than a research
question about the effectiveness of an intervention tar-
geting the structural causes of HIV? Setting priority
areas of health research seems to potentially be the re-
mit of global, national, and donors’ priority-setting pro-
cesses, whereas deciding upon specific research
questions under those areas might be more applicable to
consortia and research institutions.
Beyond identifying research priority areas and ques-
tions, priority-setting also encompasses applying those
priorities (i.e. resource allocation decisions). A ‘macro’
level decision could be: should we create a grant pro-
gram for biomedical research on neglected tropical
diseases or a grant program for social determinants
research on non-communicable diseases? A ‘micro’
level decision (within a grant program) could be:
should a trial testing the effectiveness of a HIV vac-
cine candidate be funded over a trial testing the ef-
fectiveness of a specific sexual health education
service? Applying priorities seems to be the remit of
donors and research institutions, as they are the bod-
ies that primarily oversee and implement grants
programs.
The third dimension acknowledges that global health
research is typically funded by multiple sectors (public,
private for-profit, philanthropic) with distinct aims and
accountabilities. At the national (and perhaps global
level), a decision might be made (as part of thepriority-setting process) about which research priorities
should attract public sector funding and which should
be left to the market or to philanthropies. Perhaps public
funding should be used to support global health research
on issues that market forces or charities do not. It might
be that a particularly strong charity presence means that
public funds should be redirected elsewhere. Alterna-
tively, it might be important to manage or shape the
incentives for private for-profit funders and/or philan-
thropic funders by designating priorities for them to
address. Legal or regulatory instruments might be used
in ways that can shape these decisions. The European
orphan drug legislation is an example of this kind of in-
centive management. It provides commercial protection
by allowing companies to hold patents for an extended
period of time, which is intended to make investing in
orphan drugs more commercially appealing to the pri-
vate for-profit sector.
Given these dimensions, there is a pressing need for
academic ethics research to investigate what relationship
should exist between priority-setting at not only global
and national levels but also funder, consortia, and insti-
tutional levels. As a starting point, workshop speakers
proposed a bottom-up approach to global health
research priority-setting may be ethically appropriate in
a range of contexts as opposed to the top-down ap-
proaches often employed. This concept was supported
by many (but not all) workshop participants. Bottom-up
meant an approach where institutional priorities (informed
by an “evidence of need”2 generated through community
engagement) direct national priorities, which, in turn, direct
global priorities. A normative basis for this claim might be
found in accounts of health and social justice, using
concepts of shared health governance and cognitive justice.
Shared health governance calls for shared decision-making
with meaningful participation of a wide range of
health-related stakeholders, rather than top-down and hier-
archical decision-making [39]. Knowledge democracy and
cognitive justice recognise the right of different systems of
knowledge to exist as part of dialogue and debate [43, 45].
They draw attention to inequalities in the knowledge that is
valued and produced in today’s world (e.g. “Northern” epis-
temologies over “Southern” epistemologies3 and expert
knowledge over local and indigenous ways of knowing) and
call for such inequalities to be rectified [20].
Even so, significant questions remain about whether
and when a bottom-up approach is ethically preferable
to a top-down approach. Arguably funders’ research
agendas might be usefully informed by national priorities
and locally-driven institutional priorities. The range and
complexity of these decisions might mean that alterna-
tive approaches are appropriate instead. The
context-sensitive ethical justification for bottom-up or
other approaches to connecting the different levels of
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plored further. Additionally, global health research
priority-setting processes of varying scope (i.e. differing
across the three dimensions) will generate both overlap-
ping and distinct ethical considerations relative to one
another. Conceptual and empirical work is needed to
determine what ethical considerations arise and how
they should be addressed given the scope of research
priority-setting undertaken.
Values and substantive considerations
A key overarching ethical question is what values and
substantive requirements should guide or underpin glo-
bal health research priority-setting. As noted by Nuyens
([29], p. 320-1) “setting priorities means making choices,
and those choices must refer to defined underlying
values.” Health justice has been identified as one such
guiding value for health research priority-setting in the
literature [29, 36]. To ensure such processes generate
outputs that advance health justice, it is important to
identify substantive ethical criteria to guide them. But
what substantive criteria should be applied at the different
levels? Several criteria, which may be necessary to apply in
global health research priority-setting, were suggested by
workshop participants: need, magnitude of benefits,
equity, the needs of vulnerable and disadvantaged groups,
cost-effectiveness of research, cost-effectiveness of pro-
posed interventions, and likelihood of research success.
In global health research priority-setting, the tempta-
tion is to think that research targeting conditions with
the highest health burden should be prioritised as a mat-
ter of justice. Instead, workshop participants recognised
that the decision is much more complex than that and
identified, need, rather than burden of disease, as a pos-
sible criterion for global health research priority-setting.
The two concepts are not identical; burden of disease
considerations alone are insufficient to establish that re-
search addresses a health need. What comprises a health
need depends in part on the concept of health and the
causal explanation of what determines health being
used.4 Important conceptual and empirical research
questions thus remain about what constitutes a health
need and how we should understand the relationship
between the health needs of individuals, the health needs
of groups or larger populations, and the burden of dis-
ease. Another topic to investigate is how to prioritise re-
search that addresses different health needs such as
longer length of life versus better quality of life, severe
diseases versus prevalent diseases, or child health versus
ageing. How these particular health needs ought to be
balanced and traded against each other will vary accord-
ing to different accounts of health and social justice. For
example, Powers and Faden’s theory of social justice em-
phasises protecting health early in the life course [33]. Itwould support using criteria or weighting criteria in
ways that favour research priorities focused on children’s
health needs.
The magnitude of the benefits (if the research hypoth-
esis is successfully proven), equity, and the needs of vul-
nerable and disadvantaged groups (as distinct from
needs generally) were also proposed as potential sub-
stantive criteria by workshop participants. The former
criterion entails considering the size and type of
expected benefits of the research for the host population.
The latter two criteria encompass assessing whether the
research has potential to generate evidence that will help
reduce unjust health disparities and whether the re-
search has potential to address vulnerable and disadvan-
taged groups’ most pressing health needs. Tensions will
likely arise between, for example, consideration of mag-
nitude of benefits and equity, and how to navigate them
needs to be investigated.
The cost-effectiveness of research and the cost-effective-
ness of proposed interventions are additional potentially
relevant criteria. The former comprises considering is
the research itself a good use of resources and the latter
means considering is the intervention good value for
money (compared to existing interventions). As part of
further specifying these criteria, how cost-effectiveness
should be defined will be important to explore. Ques-
tions remain about what constitutes cost-effectiveness in
global health research contexts. The assumptions and
analytical tools used in cost-effectiveness analysis reflect
certain values and setting-specific valuations, and they
can violate ethical principles like equity [40]. It is also
noted that trade-offs between the two cost-effectiveness
considerations might occur during micro-level applica-
tion of priorities. For example, should a donor support
research proposal 1—a large clinical trial with a moder-
ate chance of success that, if successful, will produce
intervention A, which will be affordable and effective on
a large scale. Or should the donor invest in research pro-
posal 2—a series of comparatively inexpensive,
small-scale studies that are likely to succeed and will
produce intervention B, which is expensive and treats a
relatively rare, localised health problem.
The likelihood of the research being successful may be
another pertinent criterion and would encompass con-
sideration of, for example, the background evidence sup-
porting the research, its novelty, and the time it will take
to yield results. Yet workshop participants noted a ten-
sion exists between prioritising research with high versus
lower degrees of uncertainty in outcomes (e.g. basic sci-
ence to support drug discovery versus health systems re-
search testing the efficacy of a proven delivery model in
a new location) since research with a high degree of un-
certainty might bear fruit in the long-term. Recognition
of the potential for this criterion to bias priority-setting
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reflected in its weighting relative to other criteria.
Further bioethics scholarship is needed to determine
the ways in which the proposed criteria are best speci-
fied to promote health justice and how their specifica-
tion may vary between priority-setting at different levels.
It should also explore what weights might be assigned to
the various criteria. Scholars have argued that the goal
of health research priority-setting is to define a portfolio
that has the greatest impact on the health of the
worst-off or disadvantaged [4, 36]. There was strong
support for this view at the workshop, where it was sug-
gested that helping improve the health of the worst-off
in a country, region, or even globally ought to be an
over-riding ethical value for setting research priorities.
This would entail weighting substantive criteria related
to equity more heavily in health research priority-setting
than those related to utility and cost-effectiveness. Cer-
tain types of research questions have been identified as
more likely to benefit people who are disadvantaged: 1)
research questions to develop more affordable, less
technology-dependent versions of existing medical prod-
ucts; 2) implementation research questions to ensure ef-
fective interventions are integrated into health systems;
and 3) health systems research questions more broadly
[4]. Assigning an equity criterion a high weight would
likely favour identifying such research questions as
priorities.
Finally, bioethics scholarship is needed to determine
what other values should also or alternatively be pursued
through global health research priority-setting and what
upholding those additional values entails (in terms of sub-
stantive criteria) at the different levels of priority-setting.
It is important to observe that health research
priority-setting decisions across levels may well involve
differing sets of values and so the set of relevant criteria to
be considered at each level may vary. Exploring the
trade-offs between different values and their associated
criteria will also be critical.Procedural considerations
Theories of justice generally call for using deliberative
processes and norms to achieve fair or just
priority-setting [18, 49]. Drawing on these theories, the
well-known ‘Accountability for Reasonableness’ (A4R)
framework was developed as a guide for achieving fair
priority-setting processes [13, 14]. The rationale was
that, in the absence of consensus about how specific
values should guide priority-setting decisions, it is essen-
tial to put in place procedures that will ensure the fair-
ness and legitimacy of those decisions [42].
With the A4R approach in mind, three procedural
considerations that can promote fairness and justice areidentified that apply to each level (global, national,
funder, consortia, institutional) of priority-setting:
a) What is the right process for making decisions
about global health research priorities?
b) Who should initiate and lead global health research
priority-setting?
c) Who should participate in global health research
priority-setting and how should they participate?
Specific sub-questions for exploration are highlighted
below within each of these broader areas. Some of these
sub-questions may apply to all levels of priority-setting
whereas others may only be relevant to a particular
level(s).
What is the right process for making decisions about global
health research priorities?
Workshop participants affirmed, at a minimum, the
right process should be a fair process; procedural re-
quirements for a fair health research priority-setting
process then need to be identified. This may demand re-
quirements corresponding to norms of deliberative
decision-making such as transparency, reciprocity,
non-coercion, qualitative equality, and accountability
amongst others [18, 21]. It is possible that A4R require-
ments (relevance, publicity, appeals/revision, and en-
forcement) might be adapted for global health research
priority-setting as part of future conceptual work. How-
ever, it will be important to take account of existing crit-
icisms and limitations of using the A4R approach when
doing so. For example, Gibson, Martin, and Singer [15]
have proposed that, beyond A4R, a requirement for pro-
moting qualitative equality is also vital to ensuring fair-
ness in decision-making in contexts of power disparities.
Upholding such a requirement entails, first, identifying
where power differences exist between participants in a
given decision-making process and, second, developing
and implementing strategies to minimise those power
differences.
Sub-questions for exploration then include: (i) what
deliberative norms should apply in global health research
priority-setting and how should procedural requirements
reflecting them be specified? (ii) are additional proced-
ural requirements ethically required to achieve fairness
and justice? A local ownership requirement may be
needed and could perhaps be reflected in how the next
two procedural considerations under discussion are
specified. A requirement for using “interpretive” priori-
ty-setting methods rather than technical, disease-driven
methods may apply where global health research
priority-setting encompasses selecting both biomedical
and non-biomedical research priorities or only
non-biomedical research priorities. As previously noted,
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essential as a matter of health justice because types of
non-biomedical research are needed to improve the
health of the most disadvantaged. Requirements for the
way in which a global health research priority-setting
process is set up and justified (and by whom) may also
be important because they can help establish the ethical
legitimacy of the resultant priorities.
Who should initiate and lead global health research
priority-setting?
Workshop participants identified leadership of priority-
setting processes and determining who should ideally
initiate such processes as an important ethical consider-
ation. The actors or institutions who assume or are
given the responsibility to undertake a global health re-
search priority-setting exercise gain considerable power,
as they make a number of decisions that shape how the
priority-setting process is conducted. For instance, they
determine who is included in the process and whether it
is structured in a way that promotes different stake-
holders having an equal opportunity to participate. They
may even have control over the substantive criteria used
to set research priorities.
A workshop speaker noted that empirical evidence
shows nearly half of health research priority-setting pro-
cesses in LMICs are initiated by international organisa-
tions, with only a third initiated by LMIC governments
and an even lower proportion (15%) commenced by
LMIC researchers [25]. Where national or institutional
research priority-setting is not led by in-country actors,
it generates ethical concern that there is a lack of local
ownership of the process. This reflects concern over
whose priorities are ultimately reflected in the outputs
of priority-setting—namely, local or external actors—
based on who “owns” the process. Given that approaches
like A4R rest on the idea that justice requires all parties
to have (and be seen to have) an equal opportunity in
deliberations, the potential for these kinds of biases are
ethically significant.
Sub-questions for exploration then might include for
example: (i) which actors, donors, or institutions should
lead or control global health research priority-setting
processes at the different levels? (ii) what is the role of
the international scientific community in priority-setting
processes? At the national level, priority-setting could be
led by the ministry of health, the national research coun-
cil, or particular prominent research institutions.
According to workshop participants, the appropriate
actor to initiate priority-setting may be national health
research councils because they are responsible for over-
seeing research in many countries. Yet this may be diffi-
cult to implement in practice since some countries do
not have bodies that coordinate health research andothers have more than one. Moreover, government sup-
port and public trust in such bodies may be quite lim-
ited. In such cases, who should lead national research
priority-setting? At the global level, it is even less clear
which type of actor(s) and/or institution(s) should be in
charge of leading and initiating global health research
priority-setting.
Who should participate in global health research priority-
setting and how should they participate?
Relevant ethical considerations about participation in glo-
bal health research priority-setting that apply at each level
are: who should be involved and how should they be in-
volved. Workshop attendees suggested participants could
potentially include national and sub-national stakeholders
spanning the weak and powerful, the organised and un-
organised, research experts, policymakers, healthcare pro-
viders, citizens, and independents (i.e. those who are not
stakeholders per se but can ensure that the process func-
tions fairly). An account of deep inclusion in health
research priority-setting argues that involving research-
producers, research-users, and research-beneficiaries is
necessary but not sufficient. Achieving deep inclusion
means ensuring that participants also span a wide
spectrum of relevant roles and demographics within those
three categories [36]. That account and the A4R frame-
work further emphasise that disadvantaged and vulnerable
groups must participate in health-related priority-setting
as a matter of fairness and justice [17, 36]. How to ensure
the involvement of the disadvantaged and less powerful
was raised as a key concern by workshop participants.
A key sub-question in this context might then be:
What is required to achieve fully inclusive global health
research priority-setting at the different levels? A com-
prehensive account would speak to what types of actors
must participate and across what demographics, what
mode of participation should be afforded to different
actors, what phases of the priority-setting process they
should participate in, and how the disadvantaged and
vulnerable should participate. A variety of modes of par-
ticipation exist, with some more “active, deliberative,
and influential” than others ([11], p. xxvii). Sherry Arn-
stein and others distinguish between lay control, part-
nership, and consultation [1, 8, 27, 38]. Lay control means
citizens are solely responsible for decision-making with (at
most) consultative input from experts. Collaboration or
partnership involves shared decision-making between
experts and citizens [38]. Consultation is characterised by
citizens being invited to give their input but having no as-
surance that it will be used by those who decide [1]. It
may entail all or some of the following: proposal-sharing,
information-giving, and/or providing feedback5 [9]. A
number of phases in “interpretive” health research
priority-setting have also been identified: planning the
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ranking criteria, and setting health research priorities. It
has been argued that earlier entry into the process is asso-
ciated with deeper inclusion [36].
Other related sub-questions to explore include: (ii)
what role should LMIC actors play in priority-setting at
the global level? (iii) should external actors be allowed to
participate in national and institutional health research
priority-setting? Currently, LMIC actors (e.g. general
public, researchers, policymakers) typically play a limited
part in setting what are meant to be global priorities
[29]. Their taking on a bigger role may be warranted as
a matter of fairness and justice. External donors often
exert undue influence on national and institutional
health research priority-setting in LMICs because they
provide the majority of research funding in LMICs [16].
As an example, during the course of one year, a Faculty
within a South African research institution received a
total of $232,000 USD in funding from within its coun-
try compared to $10,786,000 USD from the United
States’ National Institutes of Health. When the relative
proportions of health research funding from outside and
within the country are compared, it demonstrates the
extent to which international funding and the priorities
set by external donors can influence what research is
prioritised and pursued locally. A primary role for LMIC
actors may instead be generally warranted in their na-
tional and institutional research priority-setting as a
matter of justice. Accounts from political philosophy like
shared health governance would support such an ap-
proach [35].
Even if a country-based approach is warranted, it is
also necessary to consider under what circumstances
the “autonomy” of sub-national and national stake-
holders can permissibly be “influenced” by the involve-
ment of external actors in national or institutional
priority-setting. Workshop participants suggested that
the participation of external actors may be ethically
permissible in some contexts such as where countries
have corrupt governments or where certain require-
ments for the legitimacy of the priority-setting process
are not met. What those “legitimacy” requirements are
and who determines if they have been met are add-
itional questions for exploration.
A final set of sub-questions relates to the involvement
of communities: (iv) what is the nature and purpose of
community engagement in global health research
priority-setting? (v) is community engagement necessary
at each level of priority-setting? Community engagement
using various mechanisms and with different under-
standings of “community” can, where appropriate, be
built into, be prior to, or sit alongside global health
research priority-setting processes. Workshop speakers
affirmed the potential for community engagement toplay a specific and key role in global health research
priority-setting—namely, capturing an “evidence of
need” to inform the process. For example, they proposed
community engagement could inform national
priority-setting via institutional priority-setting; different
research institutions could be responsible for engaging
with their surrounding communities, including the dis-
advantaged within them, and incorporating their “evi-
dence of need” into institutional research priorities.
Accessing the voices of more disadvantaged community
members would be important to making their health
needs visible in research priorities. This more local or
ground-level evidence could then more thoroughly in-
form decisions about national and global priorities.
Where robust community engagement has occurred at
the institutional level and its outputs are used to inform
higher level priority-setting, it may then not be necessary
as part of national or global processes.
Conclusions
The ethical issues involved in setting global health re-
search priorities are complex and under-researched.
In this paper, we identify and frame a research agenda
for these complex ethical issues so that they can be
studied further (Table 1). Three sets of ethics questions
emerge. First, there are pressing ethical issues about the
interaction and relationship between the various scope
distinctions within global health research priority-setting.
Under what circumstances and in what way should insti-
tutional or national research priorities influence, or be in-
fluenced by, global priorities? Workshop participants
proposed a case could be made for bottom-up approaches
in some contexts. This idea received support from many
(but not all) workshop attendees.
The second set of ethics issues involves being clear
about the values and associated substantive require-
ments that are at stake in global health research
priority-setting. What is the range of values and relevant
substantive criteria that should be taken into account
when prioritising global health research at each of the
levels? What is the best way to specify the various sub-
stantive criteria? There was strong support at the work-
shop for the view that helping improve the health of the
worst-off in a country, region, or even globally ought to
be an over-riding ethical value for setting global health
research priorities.
The third set of ethics questions concerns the nature
of the processes that should be used to ensure fair and
just decision-making about research priorities at each
level. What is the right process for making decisions
about global health research priorities? Who should ini-
tiate and lead global health research priority-setting?
Who should participate in global health research
priority-setting and how should they participate?
Table 1 A research agenda for the ethics of global health research priority-setting
Domain of Priority-setting Research Questions Indicative Sub-questions
Scope What relationship should exist between global health
research priority-setting processes at global, national,
funder, consortia, and institutional levels?
• When is a bottom-up approach ethically preferable
to a top-down approach to connect the different levels
of priority-setting?
What ethical considerations arise and how should they
be addressed for global health research priority-setting
processes of varying scope?
• At the national level, which research priorities should
attract public sector funding and which should be left
to the market or philanthropies?
Substantive To advance the value of health justice, what substantive
criteria should guide global health research priority-setting
at different levels?
• What weights should be assigned to the substantive
criteria that guide global health research priority-setting?
• What tensions arise between substantive criteria and how
can they be navigated?
What is the best way to specify the substantive criteria
that promote health justice and should their specification
vary between priority-setting at different levels?
• How should we understand and measure health needs in
the global health context?
• How should cost-effectiveness be defined in global health
research contexts?
What other values should be pursued through global
health research priority-setting at different levels and
how do they relate to health justice?
• To advance those other values, what substantive criteria
should guide global health research priority-setting?
• What tensions exist between these criteria and those that
advance health justice?
Procedural What is the right process for making decisions about
global health research priorities at the different levels?
• What deliberative norms should apply in global health
research priority-setting and how should procedural
requirements reflecting them be specified?
• Are additional procedural requirements ethically required
to achieve fairness and justice?
Who should initiate and lead global health research
priority-setting at the different levels?
• Which actors, donors or institutions should lead or control
global health research priority-setting processes?
• What is the role of the international scientific community in
priority-setting processes?
Who should participate in global health research
priority-setting and how should they participate at
the different levels?
• What is required to achieve fully inclusive global health
research priority-setting?
• Should external actors be allowed to participate in national
and institutional global health research priority-setting?
• Is community engagement necessary at each level of
priority-setting?
• What is the nature and purpose of community engagement
in global health research priority-setting?
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important agenda for academic ethics research. Both
normative and empirical ethics methods can usefully be
employed to explore them. We emphasise the need for
more work, debates, and discussions amongst re-
searchers, ethicists, and policymakers in all three areas
and hope this call to action will stimulate an active glo-
bal discourse on the ethics of global health research
priority-setting. We further note that, while this paper
has focused on global health research, our arguments
and research agenda may be relevant to research
priority-setting more generally.
Endnotes
1A point of convergence among multiple theories of
social justice is that it is a priority and duty of justice to
avert and alleviate disadvantage [3].
2This term was used by workshop speaker Professor
James V. Lavery (Emory University) in his presentation.
3Here, “the global South is not a geographical concept,
even though the great majority of its populations live incountries of the Southern hemisphere. The South is ra-
ther a metaphor for the human suffering caused by cap-
italism and colonialism on the global level… It is a
South that also exists in the geographic North (Europe
and North America), in the form of excluded, silenced
and marginalised populations, such as undocumented
immigrants, the unemployed, ethnic or religious minor-
ities, and victims of sexism, homophobia, racism and is-
lamophobia” ([41], p. 18–19).
4Depending on what concept of health is used, needs
may be understood to comprise deficits in physical
and mental well-being (from an optimal or decent level)
or they may be defined more broadly. Venkatapuram’s
account of health justice, for instance, defines health as
individuals’ ability to achieve ten central human capabil-
ities: life; bodily health; bodily integrity; senses, imagin-
ation, and thought; emotions; practical reason; affiliation;
other species; play; and political and material control over
one’s environment [44]. Causal models of health identify
different bases of individuals’ ability to be healthy: bio-
logical, agency, physical, and/or social. Depending on what
Pratt et al. BMC Medical Ethics           (2018) 19:94 Page 10 of 11causal bases are recognised as pertinent, needs may be de-
fined as what is required to generate improvements in:
individuals’ biological capacity to achieve health, individ-
uals’ ability to act as agents of their own health and
achieve health goals they value, enabling physical environ-
mental conditions, and/or social and material structures
that promote health.
5In proposal-sharing, citizens provide their recommen-
dations or suggestions for what they would decide if they
had the power to make certain decisions. They offer
their “demands” for new research priorities, topics, or ques-
tions to be investigated by those with decision-making
power [9]. In information-giving, citizens provide informa-
tion on topics that have been selected by those who created
the decision-making space and/or by themselves. Their
information may or may not be used. Finally, providing
feedback means that citizens share their opinions on the
outputs or other aspects of a decision-making process.
They give judgements about the relevance of research
priorities set by others [9].
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